Methylthioadenosine phosphorylase compositions and methods of use in the diagnosis and treatment of proliferative disorders
Abstract
Disclosed are novel nucleic acid and peptide compositions comprising methythlioadenosine phosphorylase (MTAP) and methods of use for MTAP amino acid sequences and DNA segments comprising MTAP in the diagnosis of human cancers and development of MTAP-specific antibodies. Also disclosed are methods for the diagnosis and treatment of tumors and other proliferative cell disorders, and idenification tumor suppressor genes and gene products from the human 9p21-p22 chromosome region. Such methods are useful in the diagnosis of multiple tumor types such as bladder cancer, lung cancer, breast cancer, pancreatic cancer, brain tumors, lymphomas, gliomas, melanomas, and leukemias.
- Inventors:
- Issue Date:
- Research Org.:
- Arch Development Corporation, Chicago, IL (United States)
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1175285
- Patent Number(s):
- 6870037
- Application Number:
- 08/674,311
- Assignee:
- Arch Development Corporation (Chicago, IL)
- Patent Classifications (CPCs):
-
C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07H - SUGARS
- DOE Contract Number:
- FG02-86ER60408
- Resource Type:
- Patent
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 60 APPLIED LIFE SCIENCES
Citation Formats
Olopade, Olufunmilayo I. Methylthioadenosine phosphorylase compositions and methods of use in the diagnosis and treatment of proliferative disorders. United States: N. p., 2005.
Web.
Olopade, Olufunmilayo I. Methylthioadenosine phosphorylase compositions and methods of use in the diagnosis and treatment of proliferative disorders. United States.
Olopade, Olufunmilayo I. Tue .
"Methylthioadenosine phosphorylase compositions and methods of use in the diagnosis and treatment of proliferative disorders". United States. https://www.osti.gov/servlets/purl/1175285.
@article{osti_1175285,
title = {Methylthioadenosine phosphorylase compositions and methods of use in the diagnosis and treatment of proliferative disorders},
author = {Olopade, Olufunmilayo I.},
abstractNote = {Disclosed are novel nucleic acid and peptide compositions comprising methythlioadenosine phosphorylase (MTAP) and methods of use for MTAP amino acid sequences and DNA segments comprising MTAP in the diagnosis of human cancers and development of MTAP-specific antibodies. Also disclosed are methods for the diagnosis and treatment of tumors and other proliferative cell disorders, and idenification tumor suppressor genes and gene products from the human 9p21-p22 chromosome region. Such methods are useful in the diagnosis of multiple tumor types such as bladder cancer, lung cancer, breast cancer, pancreatic cancer, brain tumors, lymphomas, gliomas, melanomas, and leukemias.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2005},
month = {3}
}
Works referenced in this record:
Construction of a 2.8-megabase yeast artificial chromosome contig and cloning of the human methylthioadenosine phosphorylase gene from the tumor suppressor region on 9p21.
journal, July 1995
- Olopade, O. I.; Pomykala, H. M.; Hagos, F.
- Proceedings of the National Academy of Sciences, Vol. 92, Issue 14
The use of methylthioadenosine phosphorylase activity to select for human chromosome 9 in interspecies and intraspecies hybrid cells
journal, September 1993
- Porterfield, Bruce W.; Pomykala, Helen; Maltepe, Emin
- Somatic Cell and Molecular Genetics, Vol. 19, Issue 5
Analysis of tumor suppressor gene on human chromosome 9 in mouse x human somatic cell hybrids
journal, September 1994
- Porterfield, Bruce W.; Olopade, Olufunmilayo I.; Rowley, Janet D.
- Somatic Cell and Molecular Genetics, Vol. 20, Issue 5
Deficiency of methylthioadenosine phosphorylase in human leukemic cells in vivo
journal, December 1982
- Kamatani, N.; Yu, Al; Carson, Da
- Blood, Vol. 60, Issue 6
Measurement of 5′-methylthioadenosine in patients with neoplasms
journal, January 1990
- Kaneko, Kiyoko; Fujimori, Shin; Kanbayashi, Takaaki
- International Journal of Cancer, Vol. 45, Issue 1
Cytogenetics of non-small cell lung cancer: Analysis of consistent non-random abnormalities
journal, July 1990
- Lukeis, Robyn; Irving, Louis; Garson, Margaret
- Genes, Chromosomes and Cancer, Vol. 2, Issue 2
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
journal, December 1993
- Serrano, Manual; Hannon, Gregory J.; Beach, David
- Nature, Vol. 366, Issue 6456
Inhibition of ras-induced proliferation and cellular transformation by p16INK4
journal, January 1995
- Serrano, M.; Gomez-Lahoz, E.; DePinho, R.
- Science, Vol. 267, Issue 5195
Germline p16 mutations in familial melanoma
journal, September 1994
- Hussussian, Christopher J.; Struewing, Jeffery P.; Goldstein, Alisa M.
- Nature Genetics, Vol. 8, Issue 1
Mapping a Putative Tumor Suppressor Gene on Chromosome 9 Bands p21-p22 with Microdissection Probes
journal, November 1994
- Bohlander, Stefan K.; Dreyling, Martin H.; Hagos, Fitsum
- Genomics, Vol. 24, Issue 2
Mapping of the shortest region of overlap of deletions of the short arm of chromosome 9 associated with human neoplasia
journal, October 1992
- Olopade, Olufunmilayo I.; Bohlander, Stefan K.; Pomykala, Helen
- Genomics, Vol. 14, Issue 2
REPORT on the Third International Workshop on Chromosome 9
journal, July 1994
- Povey, S.; Armour, J.; Farndon, P.
- Annals of Human Genetics, Vol. 58, Issue 3
Selective killing of human malignant cell lines deficient in methylthioadenosine phosphorylase, a purine metabolic enzyme.
journal, February 1981
- Kamatani, N.; Nelson-Rees, W. A.; Carson, D. A.
- Proceedings of the National Academy of Sciences, Vol. 78, Issue 2
Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias [see comments]
journal, December 1994
- Hebert, J.; Cayuela, Jm; Berkeley, J.
- Blood, Vol. 84, Issue 12
A method for screening arrayed cosmid libraries with mega insert yeast artificial chromosomes
journal, January 1995
- Dreyling, Martin H.; Olopade, Olufunmilayo I.; Bohlander, Stefan K.
- Nucleic Acids Research, Vol. 23, Issue 6
Detection of 9p deletions in leukemia cell lines by interphase fluorescence in situ hybridization with YAC-derived probes
journal, August 1995
- Dreyling, M. H.; Kobayashi, H.; Olopade, O. I.
- Cancer Genetics and Cytogenetics, Vol. 83, Issue 1
Dependence of adenine production upon polyamine synthesis in cultured human lymphoblasts
journal, July 1981
- Kamatani, Naoyuki; Carson, Dennis A.
- Biochimica et Biophysica Acta (BBA) - General Subjects, Vol. 675, Issue 3-4
Genetic Alterations during Colorectal-Tumor Development
journal, September 1988
- Vogelstein, Bert; Fearon, Eric R.; Hamilton, Stanley R.
- New England Journal of Medicine, Vol. 319, Issue 9
5′-Methylthioadenosine is the Major Source of Adenine in Human Cells
book, January 1984
- Kamatani, Naoyuki; Kubota, Masaru; Willis, Erik H.
- Advances in Experimental Medicine and Biology
5′-methylthioadenosine in urine from normal subjects and cancer patients
journal, November 1984
- Kaneko, K.; Fujimori, S.; Kamatani, N.
- Biochimica et Biophysica Acta (BBA) - General Subjects, Vol. 802, Issue 2
Disturbance in the metabolism of 5′-methylthioadenosine and adenine in patients with neoplastic diseases, and in those with a deficiency in adenine phosphoribosyltransferase
journal, September 1991
- Kaneko, Kiyoko; Fujimori, Shin; Kumakawa, Toshiro
- Metabolism, Vol. 40, Issue 9
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
journal, September 1994
- Kamb, A.; Shattuck-Eidens, D.; Eeles, R.
- Nature Genetics, Vol. 8, Issue 1
Codeletion of the genes for p16INK4, methylthioadenosine phosphorylase, interferon-α1, interferon-β1, and other 9p21 markers in human malignant cell lines
journal, January 1996
- Zhang, Hongyang; Chen, Zhi-Hao; Savarese, Todd M.
- Cancer Genetics and Cytogenetics, Vol. 86, Issue 1
Sequential metabolism of 5′-isobutylthioadenosine by methylthioadenosine phosphorylase and purine-nucleoside phosphorylase in viable human cells
journal, February 1982
- Kamatani, Naoyuki; Willis, Erik H.; Carson, Dennis A.
- Biochemical and Biophysical Research Communications, Vol. 104, Issue 4
p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters
journal, February 1992
- Thompson, A. M.; Anderson, T. J.; Condie, A.
- International Journal of Cancer, Vol. 50, Issue 4
Metabolism to methionine and growth stimulation by 5′-methylthioadenosine and 5′-methylthioinosine in mammalian cells
journal, April 1983
- Carson, Dennis A.; Willis, Erik H.; Kamatani, Naoyuki
- Biochemical and Biophysical Research Communications, Vol. 112, Issue 2
p16 gene homozygous deletions in acute lymphoblastic leukemia
journal, February 1995
- Quesnel, B.; Preudhomme, C.; Philippe, N.
- Blood, Vol. 85, Issue 3
A cell cycle regulator potentially involved in genesis of many tumor types
journal, April 1994
- Kamb, A.; Gruis, N.; Weaver-Feldhaus, J.
- Science, Vol. 264, Issue 5157
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
journal, April 1994
- Nobori, Tsutomu; Miura, Kaoru; Wu, David J.
- Nature, Vol. 368, Issue 6473
5′-Methylthioadenosine Phosphorylase Deficiency in Malignant Cells: Recessive Expression of the Defective Phenotype in Intra-Species (Mouse X Mouse) Hybrids
book, January 1984
- Kamatani, Naoyuki; Kubota, Masaru; Willis, Erik H.
- Advances in Experimental Medicine and Biology